Kobayashi Pharmaceutical Co. Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2012; Revised Earnings Guidance for the Full Year Ending March 31, 2013; Forecasts Dividend for the Year Ending March 31, 2013
January 29, 2013
Share
Kobayashi Pharmaceutical Co. Ltd. reported consolidated earnings results for the nine months ended December 31, 2012. For the period, the company reported net sales of ¥94,828 million compared to ¥102,736 million a year ago. Operating income was ¥14,615 million compared to ¥16,743 million a year ago. Ordinary income was ¥15,968 million compared to ¥17,185 million a year ago. Net income was ¥11,606 million or ¥283.44 per share compared to ¥9,473 million or ¥231.35 per share a year ago. Income before income taxes was ¥17,563 million compared to ¥16,207 million a year ago.
The company revised earnings guidance for the full year ending March 31, 2013. For the period, the company expects net sales of ¥122,000 million, operating income of ¥16,800 million, ordinary income of ¥18,300 million and net income of ¥12,300 million or ¥300.38 per share.
The company forecasts dividend of ¥43.00 per share for the year ending March 31, 2013 compared to ¥43 for the same period a year ago.
KOBAYASHI PHARMACEUTICAL CO., LTD. a drug manufacturer. The Company operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.
Kobayashi Pharmaceutical Co. Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2012; Revised Earnings Guidance for the Full Year Ending March 31, 2013; Forecasts Dividend for the Year Ending March 31, 2013